Ac-YVAD-AFCCAS# 219137-85-6 |
- Amyloid β-Protein (1-15)
Catalog No.:BCC1003
CAS No.:183745-81-5
- Beta-Amyloid (1-11)
Catalog No.:BCC1002
CAS No.:190436-05-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 219137-85-6 | SDF | Download SDF |
| PubChem ID | 16760708 | Appearance | Powder |
| Formula | C33H36F3N5O10 | M.Wt | 719.66 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in DMSO | ||
| Chemical Name | (3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-4-oxo-4-[[2-oxo-4-(trifluoromethyl)chromen-7-yl]amino]butanoic acid | ||
| SMILES | CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC1=CC2=C(C=C1)C(=CC(=O)O2)C(F)(F)F)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C | ||
| Standard InChIKey | GWKJISJKNKIJNP-DEQDFGQZSA-N | ||
| Standard InChI | InChI=1S/C33H36F3N5O10/c1-15(2)28(41-31(49)23(38-17(4)42)11-18-5-8-20(43)9-6-18)32(50)37-16(3)29(47)40-24(14-26(44)45)30(48)39-19-7-10-21-22(33(34,35)36)13-27(46)51-25(21)12-19/h5-10,12-13,15-16,23-24,28,43H,11,14H2,1-4H3,(H,37,50)(H,38,42)(H,39,48)(H,40,47)(H,41,49)(H,44,45)/t16-,23-,24-,28-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Fluorogenic peptide substrate for caspase-1 (ICE). |
Ac-YVAD-AFC Dilution Calculator
Ac-YVAD-AFC Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3895 mL | 6.9477 mL | 13.8955 mL | 27.7909 mL | 34.7386 mL |
| 5 mM | 0.2779 mL | 1.3895 mL | 2.7791 mL | 5.5582 mL | 6.9477 mL |
| 10 mM | 0.139 mL | 0.6948 mL | 1.3895 mL | 2.7791 mL | 3.4739 mL |
| 50 mM | 0.0278 mL | 0.139 mL | 0.2779 mL | 0.5558 mL | 0.6948 mL |
| 100 mM | 0.0139 mL | 0.0695 mL | 0.139 mL | 0.2779 mL | 0.3474 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Ac-YVAD-AFC
- 3'-Methoxydaidzein
Catalog No.:BCN4082
CAS No.:21913-98-4
- 2,3-Dihydro-3-methoxywithaferin A
Catalog No.:BCN7943
CAS No.:21902-96-5
- Boc-ß-HoGlu(OBzl)-OH
Catalog No.:BCC3233
CAS No.:218943-30-7
- Z-Trp(Boc)-OH.DCHA
Catalog No.:BCC2749
CAS No.:218938-57-9
- KNK437
Catalog No.:BCC6399
CAS No.:218924-25-5
- Euphorbia factor L8
Catalog No.:BCN3785
CAS No.:218916-53-1
- 5,15-Diacetyl-3-benzoyllathyrol
Catalog No.:BCN1196
CAS No.:218916-52-0
- Euphorbia factor L2
Catalog No.:BCN3783
CAS No.:218916-51-9
- Ciwujiatone
Catalog No.:BCN7598
CAS No.:218901-26-9
- Taraxeryl acetate
Catalog No.:BCN4937
CAS No.:2189-80-2
- 1-Phenyloctane
Catalog No.:BCN2227
CAS No.:2189-60-8
- Boc-Orn-OH
Catalog No.:BCC3427
CAS No.:21887-64-9
- Hydroxyzine 2HCl
Catalog No.:BCC4519
CAS No.:2192-20-3
- 2-Hydroxy-3,4,5,6-tetramethoxychalcone
Catalog No.:BCN1489
CAS No.:219298-74-5
- H-ß-HoIle-OH.HCl
Catalog No.:BCC3235
CAS No.:219310-10-8
- Boc-Nle-OH.DCHA
Catalog No.:BCC3297
CAS No.:21947-32-0
- trans-Cinnamic anhydride
Catalog No.:BCN7914
CAS No.:21947-71-7
- Boc-Cys(Trt)-OH
Catalog No.:BCC3380
CAS No.:21947-98-8
- Littorine
Catalog No.:BCN1917
CAS No.:21956-47-8
- Trans-Pinosylvin dimethyl ether
Catalog No.:BCN3495
CAS No.:21956-56-9
- PD 173074
Catalog No.:BCC3662
CAS No.:219580-11-7
- 4',7-Dihydroxyflavone
Catalog No.:BCN3758
CAS No.:2196-14-7
- beta-Hydroxypropiovanillone
Catalog No.:BCN4938
CAS No.:2196-18-1
- (R)-Coclaurine
Catalog No.:BCN8348
CAS No.:2196-60-3
Activation of caspase-3 and apoptosis in cerebellar granule cells.[Pubmed:9590441]
J Neurosci Res. 1998 May 1;52(3):334-41.
Caspase-3 activity increased dramatically in cytosolic extracts of rat cerebellar granule cells exposed to apoptotic conditions (basal medium Eagle (BME) containing 5 mM K+ without serum) when assayed with Ac-DEVD-amc, but not with Ac-YVAD-AFC, a preferred substrate for caspase-1. This provided a basis to examine relationships between enzyme activity and cell viability for purposes of selecting an optimal time for comparing neuroprotective agents or strategies. Exposure of neurons to an apoptotic medium containing 5 mM K+ in absence of serum led to a rapid 5- to 10-fold increase in caspase-3 within 2-4 hr but without significant cell loss, or morphological alterations. Exposure to apoptotic medium followed by replacement with maintenance medium containing 25 mM K+ and serum led to a rapid fall in caspase-3 and prevention of cell death. This strategy was not effective after 13 hr exposure despite a large fall in enzyme activity. These temporal changes infer systems for rapid enzyme turnover and/or activation of cytoplasmic components linked to later DNA degradation. The effects of cycloheximide point to requirements for protein synthesis, and those of Glu exclude a caspase-3 dependent pathway for necrotic cell damage. Brief treatment with 10 microM LIGA20, an anti-necrotic agent, also attenuated cell loss and caspase-3 activity, indicating a broad spectrum of neuroprotection. Rapid and long-lasting effects, together with its biophysical properties, suggest that this semisynthetic ganglioside acted upstream at or near a membrane site. As such, gangliosides provide useful agents to further probe pathways relevant to neuronal death in culture.
